Pamela W Duncan,
Katherine J Sullivan,
Andrea L Behrman,
Stanley P Azen,
Samuel S Wu,
Stephen E Nadeau,
Bruce H Dobkin,
Dorian K Rose,
Julie K Tilson,
Steven Cen,
Sarah K Hayden and
LEAPS Investigative Team
Abstract
We stratified 408 participants who had had a stroke 2 months earlier according to the extent of walking impairment--moderate (able to walk 0.4 to <0.8 m per second) or severe (able to walk <0.4 m per second)--and randomly assigned them to one of three training groups. One group received training on...
|
PMID: 21612471
PDF is available here.
Samer S SS Najjar,
Sunil V SV Rao,
Chiara C Melloni,
Subha V SV Raman,
Thomas J TJ Povsic,
Laura L Melton,
Gregory W GW Barsness,
Kristi K Prather,
John F JF Heitner,
Rakhi R Kilaru,
Luis L Gruberg,
Vic V Hasselblad,
Adam B AB Greenbaum,
Manesh M Patel,
Raymond J RJ Kim,
Mark M Talan,
Luigi L Ferrucci,
Dan L DL Longo,
Edward G EG Lakatta,
Robert A RA Harrington and
Abstract
Acute ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality. In experimental models of MI, erythropoietin reduces infarct size and improves left ventricular (LV) function.
|
PMID: 21558517
PDF is available here.
Abstract
We sought to evaluate the impact of personalized coronary heart disease and stroke risk communication on patients' knowledge, beliefs, and health behavior....
|
PMID: 21473965
PDF is available here.
Abstract
We evaluated how body fat percentage, measured by a portable near-infrared interactance (NIR) device predicts cardiovascular (CVD), coronary heart disease (CHD), and ischemic stroke events in a prospective population-based survey. The study population consisted of 2,842 men and 3,196 women, who part...
|
PMID: 20966903
PDF is available here.
Abstract
Information relating the outcome of percutaneous coronary intervention to diabetes mellitus or hypertension is limited. The study objective was to describe the outcome in patients undergoing percutaneous coronary intervention in relation to diabetes and hypertension.
|
PMID: 21396511
PDF is available here.
Abstract
Therapeutic angiogenesis is a novel treatment for ischemic stroke, and vascular endothelial growth factor (VEGF) is a key angiogenic and neuroprotective pharmacological candidate for therapy. However, the greatest challenge of preclinical studies is demonstrating that VEGF-based ther...
|
PMID: 20874695
PDF is available here.